Exscientia pulls in $225m Series D
Exscientia, a clinical stage pharmatech company, has raised $225 million in Series D funding.
Exscientia, a clinical stage pharmatech company, has raised $225 million in Series D funding.
Copyright PEI Media
Not for publication, email or dissemination